David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA
Center for the Study of Healthcare Innovation, Implementation and Policy, VA Greater Los Angeles Healthcare System, Los Angeles, California, USA.
BMJ Open Diabetes Res Care. 2021 Jan;9(1). doi: 10.1136/bmjdrc-2020-001802.
To examine the association of a novel disease-specific health plan, known as the Diabetes Health Plan (DHP), with emergency room (ER) and hospital utilization among patients with diabetes and pre-diabetes.
Quasi-experimental design, with employer group as the unit of analysis, comparing changes in any ER and inpatient hospital utilization over a 3-year period. Inverse probability weighting was used to control for differences between employers purchasing DHP versus standard plans. Estimated differences in utilization are calculated as average treatment effects on the treated. We used employees and dependents from employer groups contracting with a large, national private insurer between 2009 and 2012. Eligibility and claims data from continuously covered employees and dependents with diabetes and pre-diabetes (n=74 058) were aggregated to the employer level. The analysis included 9 DHP employers (n=7004) and 183 control employers (n=67 054).
DHP purchase was associated with 2.4 and 1.8 percentage points absolute reduction in mean rates of any ER utilization, representing 13% and 10% relative reductions at 1 and 2 years post-DHP (p=0.012 and p=0.046, respectively). There was no significant association between DHP purchase and hospital utilization.
Employers purchasing diabetes-specific health benefit designs may experience lower rates of resource-intensive services such as ER utilization.
本研究旨在探讨一种新型疾病特异性健康计划(Diabetes Health Plan,DHP)与糖尿病和糖尿病前期患者急诊室(ER)和住院利用之间的关联。
采用准实验设计,以雇主群体为分析单位,比较了 3 年内任何 ER 和住院利用的变化。采用逆概率加权法控制了购买 DHP 与标准计划的雇主之间的差异。利用倾向评分治疗效果平均估计了利用方面的差异。我们使用了在 2009 年至 2012 年间与一家大型私营保险公司签订合同的雇主群体中的员工及其家属的数据。将连续参保的糖尿病和糖尿病前期患者(n=74058)的资格和理赔数据汇总到雇主层面。分析包括 9 家 DHP 雇主(n=7004)和 183 家对照雇主(n=67054)。
DHP 的购买与任何 ER 利用的平均率绝对降低了 2.4 和 1.8 个百分点,分别代表了 1 年和 2 年后 DHP 的相对减少了 13%和 10%(p=0.012 和 p=0.046)。DHP 的购买与住院利用之间没有显著关联。
购买糖尿病特异性健康福利设计的雇主可能会经历较低的资源密集型服务利用率,如急诊室利用率。